Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

Stephen Senn*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)414-416
Number of pages3
JournalStatistics in Biopharmaceutical Research
Volume16
Issue number4
DOIs
Publication statusPublished - 2024
Externally publishedYes

Cite this